Tirzepatide emerges a groundbreaking pharmaceutical agent for individuals struggling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://rsaxmmm929229.newsbloger.com/41166842/tirzepatide-a-new-frontier-in-diabetes-treatment